AstraZeneca profits soar on cancer drugs, Alexion buy

British drugmaker AstraZeneca on Thursday posted surging annual net profit, boosted by cancer treatments and the integration of biotech unit Alexion following a blockbuster takeover.

Continue Reading


News Source: medicalxpress.com


Posted

in

by

Tags: